Which cancer patients need prophylaxis for DVT and pulmonary embolism?
www.pulmccm.org
People with cancer have the highest rates of deep venous thrombosis (DVT) and pulmonary embolism (PE). However, the risk of venous thromboembolism varies widely by cancer type and between patients. Daily anticoagulant use can reduce the risk of DVT and pulmonary embolism, but at a cost of increased bleeding risk, patient inconvenience and discomfort, and cost. Which cancer patients should receive anticoagulant prophylaxis against venous thromboembolism?
Which cancer patients need prophylaxis for DVT and pulmonary embolism?
Which cancer patients need prophylaxis for…
Which cancer patients need prophylaxis for DVT and pulmonary embolism?
People with cancer have the highest rates of deep venous thrombosis (DVT) and pulmonary embolism (PE). However, the risk of venous thromboembolism varies widely by cancer type and between patients. Daily anticoagulant use can reduce the risk of DVT and pulmonary embolism, but at a cost of increased bleeding risk, patient inconvenience and discomfort, and cost. Which cancer patients should receive anticoagulant prophylaxis against venous thromboembolism?